New Zealand markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.5400+0.4000 (+12.74%)
At close: 04:00PM EDT
3.8000 +0.26 (+7.34%)
After hours: 07:56PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
4,595
20,054
27,605
1,859
Total cash
4,595
20,054
27,605
1,859
Net receivables
-
-
0
831
Other current assets
-
-
-
26
Total current assets
6,884
25,795
32,714
2,930
Non-current assets
Other long-term assets
431
21
15
11
Total non-current assets
431
21
15
11
Total assets
7,315
25,816
32,729
2,941
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
9,161
7,703
518
249
Accounts payable
4,632
2,076
3,687
3,153
Accrued liabilities
5,238
5,769
2,844
42,762
Other current liabilities
17
37
4,874
-
Total current liabilities
19,048
15,585
11,923
46,164
Non-current liabilities
Long-term debt
-
2,822
-
548
Total non-current liabilities
0
2,822
0
548
Total liabilities
19,048
18,407
11,923
46,712
Stockholders' equity
Common stock
87
67
59
43
Retained earnings
-253,147
-222,997
-183,243
-90,180
Accumulated other comprehensive income
-3
0
-
-
Total stockholders' equity
-11,733
7,409
20,806
-43,771
Total liabilities and stockholders' equity
7,315
25,816
32,729
2,941